The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Hasan, Lubna
    Individual (2 offsprings)
    Officer
    2008-08-20 ~ now
    OF - Secretary → CIF 0
    Mrs Lubna Hasan
    Born in April 1982
    Individual (2 offsprings)
    Person with significant control
    2017-09-19 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
  • 2
    Hasan, Syed Atif, Dr
    Doctor born in December 1980
    Individual (4 offsprings)
    Officer
    2008-08-20 ~ now
    OF - Director → CIF 0
Ceased 1
  • Dr Syed Atif Hasan
    Born in December 1980
    Individual (4 offsprings)
    Person with significant control
    2016-04-06 ~ 2017-09-19
    PE - Has significant influence or controlCIF 0
parent relation
Company in focus

AVICENNA MEDICAL LIMITED

Standard Industrial Classification
85422 - Post-graduate Level Higher Education
86210 - General Medical Practice Activities
Brief company account
Average Number of Employees
12023-04-01 ~ 2024-03-31
12022-04-01 ~ 2023-03-31
Fixed Assets - Investments
238,928 GBP2024-03-31
248,584 GBP2023-03-31
Fixed Assets
238,928 GBP2024-03-31
248,584 GBP2023-03-31
Debtors
Current
4,563 GBP2024-03-31
4,563 GBP2023-03-31
Cash at bank and in hand
4,234 GBP2024-03-31
1,662 GBP2023-03-31
Current Assets
8,797 GBP2024-03-31
6,225 GBP2023-03-31
Creditors
Current, Amounts falling due within one year
-8,692 GBP2024-03-31
-10,809 GBP2023-03-31
Net Current Assets/Liabilities
105 GBP2024-03-31
-4,584 GBP2023-03-31
Total Assets Less Current Liabilities
239,033 GBP2024-03-31
244,000 GBP2023-03-31
Creditors
Non-current, Amounts falling due after one year
-237,259 GBP2024-03-31
-244,765 GBP2023-03-31
Net Assets/Liabilities
1,774 GBP2024-03-31
-765 GBP2023-03-31
Equity
Called up share capital
1,000 GBP2024-03-31
1,000 GBP2023-03-31
Retained earnings (accumulated losses)
774 GBP2024-03-31
-1,765 GBP2023-03-31
Equity
1,774 GBP2024-03-31
-765 GBP2023-03-31
Trade Debtors/Trade Receivables
Current
4,563 GBP2024-03-31
4,563 GBP2023-03-31
Cash and Cash Equivalents
4,234 GBP2024-03-31
1,662 GBP2023-03-31
Bank Borrowings
Current
7,507 GBP2024-03-31
7,268 GBP2023-03-31
Other Creditors
Current
225 GBP2024-03-31
2,071 GBP2023-03-31
Accrued Liabilities/Deferred Income
Current
960 GBP2024-03-31
1,470 GBP2023-03-31
Creditors
Current
8,692 GBP2024-03-31
10,809 GBP2023-03-31
Bank Borrowings
Non-current
237,259 GBP2024-03-31
244,765 GBP2023-03-31
Creditors
Non-current
237,259 GBP2024-03-31
244,765 GBP2023-03-31
Advances or credits given to directors
-225 GBP2024-03-31
-2,071 GBP2023-04-01
-1,729 GBP2022-04-01
Advances or credits made to directors during the period
-6,814 GBP2023-04-01 ~ 2024-03-31
-342 GBP2022-04-01 ~ 2023-03-31
Advances or credits repaid by directors
8,660 GBP2023-04-01 ~ 2024-03-31

  • AVICENNA MEDICAL LIMITED
    Info
    Registered number 06677611
    44 Grasmere Avenue, Wimbledon, London SW19 3DX
    Private Limited Company incorporated on 2008-08-20 (16 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-18
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.